Slashdot Mirror
Domain: fiercepharma.com
Stories and comments across the archive that link to fiercepharma.com.
Stories · 2
-
China Negotiating For Cheaper Cancer Drugs (reuters.com)
hackingbear writes: "China's medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients," reports Reuters. "The State Medical Insurance Administration said it was preparing to include more cancer drugs on its list of medicines eligible for reimbursement, and said 10 foreign and eight domestic pharmaceutical companies had expressed a willingness to work with the authority."
Unlike India, or what we may have been told, China enforces pharmaceutical patents rigorously. Recently, the Chinese box office hit Dying to Survive, which told the real life story of a leukemia patient/businessman put on trial due to smuggling imitation drugs to help fellow patients who cannot pay the exorbitant cost of a drug produced by a Swiss pharmaceutical giant, has brought in huge revenues and rave reviews since the movie was released on July 5. Last year, China forced two rounds of NRDL negotiations after seven years of stasis. More than a dozen cancer drugs, including AstraZeneca's Iressa and Roche's Herceptin, are now covered by the country's insurance program, but only after the companies agreed to huge discounts -- a typical move trading lower prices for higher volume. Demand for Herceptin, for example, surged after the discount and triggered a national shortage. -
Drug Companies Lose Special Protection On Facebook
Hugh Pickens writes "Christian Torres writes that Facebook and the pharmaceutical industry have had an uneasy partnership in recent years and many drug companies didn't join the site until Facebook gave them a privilege that others do not have — blocking the public's ability to openly comment on a page Wall. But that's about to change when, starting Monday, most drug company pages will have to have open Walls. 'We think these policy changes support consistency for the Facebook Pages product and encourage an authentic dialogue between people and businesses on Facebook,' wrote Facebook in an email. AstraZeneca, which sells the antidepressant Seroquel, already shut down a page devoted to depression, Johnson & Johnson says it will close four of its pages, and other companies say they will monitor their pages more closely once the changes take effect. The industry is concerned that users might write about bad side effects, promote off-label use or make inappropriate statements about a product, and that the comments could raise concerns from government regulators."